Our Latest Blog Articles

The ExitPoints Blog is where we publish current thinking across market commentary, trading education, strategy updates, research, and company news.

Equities Insights and Analysis

Dave’s Analysis: June 23, 2025

Company Overview: Immunic Inc. (NASDAQ: IMUX) Immunic Inc. is a clinical-stage biopharmaceutical company pioneering the development of selective, orally administered

Read More »